Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
New Evidence Suggests Frequent Lipid Monitoring May be Unnecessary
...
Register
Strategic Alliances, Partnerships & Collaborations Analysis – December 2017
...
Register
Mergers, Acquisitions & Asset Sales Analysis – December 2017
...
Register
The 10 Assumptions NOT to Make when Doing Your OSHA 300s
...
Register
CLIA Corner: FDA Moves to Boost CLIA Waiver Transparency
...
Register
Medicare Reimbursement: CMS Finalizes Hospital Outpatient Prospective Payment Changes for 2018
...
Register
High-Deductible Plans Tied to Reduced Use of Health Care, Including Diagnostic Testing
From - Laboratory Industry Report
People enrolled in high-deductible health plans (HDHPs) cut their use of health services, including laboratory testing, according to…
OIG Work Plan Monthly Review: November 2017
From - G2 Compliance Advisor
The OIG added four new items to its Work Plan this month, all of which have potential indirect effects on clinical labs involved in providing the…
Millennium Labs Bankruptcy Plan Stays on Track despite Lender Opposition
From - National Intelligence Report
It has been nearly two years since Millennium went into Chapter 11 but the case continues to make news. After agreeing to…
Federal Guidelines for Workplace Drug Testing Add Opioids
From - Diagnostic Testing & Emerging Technologies
As of Oct. 1, new federal mandatory guidelines for workplace drug testing expanded to include the authority to test for…